Re-evaluating the potential of immunoprophylaxis and/or immunotherapy for infections caused by multidrug resistant Klebsiella pneumoniae.
作者信息
Kobayashi Scott D, DeLeo Frank R
机构信息
Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA.
出版信息
Future Microbiol. 2018 Sep;13(12):1343-1346. doi: 10.2217/fmb-2018-0189. Epub 2018 Sep 26.
Abstract
摘要
相似文献
1
Re-evaluating the potential of immunoprophylaxis and/or immunotherapy for infections caused by multidrug resistant Klebsiella pneumoniae.重新评估免疫预防和/或免疫治疗对多重耐药肺炎克雷伯菌引起的感染的潜力。
Future Microbiol. 2018 Sep;13(12):1343-1346. doi: 10.2217/fmb-2018-0189. Epub 2018 Sep 26.
2
Vaccine Protection against Multidrug-Resistant Klebsiella pneumoniae in a Nonhuman Primate Model of Severe Lower Respiratory Tract Infection.疫苗对严重下呼吸道感染非人灵长类动物模型中多重耐药肺炎克雷伯菌的保护作用。
mBio. 2019 Dec 17;10(6):e02994-19. doi: 10.1128/mBio.02994-19.
3
Development of immunization trials against Klebsiella pneumoniae.针对肺炎克雷伯菌的免疫试验的发展。
Vaccine. 2012 Mar 23;30(14):2411-20. doi: 10.1016/j.vaccine.2011.11.027. Epub 2011 Nov 17.
4
[Effect of a hydroxylamine Klebsiella vaccine on the rate of elimination of the causative agent and on indices of humoral immunity].[羟胺克雷伯菌疫苗对病原体清除率及体液免疫指标的影响]
Zh Mikrobiol Epidemiol Immunobiol. 1988 Sep(9):75-9.
5
Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.靶向包膜下抗原以预防肺炎克雷伯菌感染。
Vaccine. 2008 Oct 16;26(44):5649-53. doi: 10.1016/j.vaccine.2008.07.100. Epub 2008 Aug 24.
6
Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae.免疫逃避驱动的 O2 血清型流行情况以及针对多药耐药肺炎克雷伯菌的治疗性抗体的潜力。
Nat Commun. 2017 Dec 8;8(1):1991. doi: 10.1038/s41467-017-02223-7.
7
Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model.用外膜蛋白 OmpK17 和 OmpK36 进行免疫接种可在小鼠感染模型中引发针对肺炎克雷伯菌的保护作用。
Microb Pathog. 2018 Jun;119:12-18. doi: 10.1016/j.micpath.2018.04.004. Epub 2018 Apr 4.
8
Phagocytosis and Killing of Carbapenem-Resistant ST258 Klebsiella pneumoniae by Human Neutrophils.人中性粒细胞对碳青霉烯耐药 ST258 肺炎克雷伯菌的吞噬与杀伤作用
J Infect Dis. 2016 May 15;213(10):1615-22. doi: 10.1093/infdis/jiw001. Epub 2016 Jan 14.
9
Multidrug resistance determinants from NDM-1-producing Klebsiella pneumoniae in the USA.美国产NDM-1肺炎克雷伯菌的多重耐药决定因素。
Int J Antimicrob Agents. 2012 Sep;40(3):282-4. doi: 10.1016/j.ijantimicag.2012.05.019. Epub 2012 Jul 18.
10
Resistance profiles and resistome mapping of multidrug resistant carbapenem-hydrolyzing Klebsiella pneumoniae strains isolated from the nares of preterm neonates.从早产儿鼻腔分离出的耐多药碳青霉烯水解肺炎克雷伯菌菌株的耐药谱及耐药基因组图谱
Int J Antimicrob Agents. 2019 Apr;53(4):535-537. doi: 10.1016/j.ijantimicag.2018.12.002. Epub 2018 Dec 17.
引用本文的文献
1
Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections.预防医院获得性细菌感染疫苗的临床开发挑战。
Front Immunol. 2020 Aug 5;11:1755. doi: 10.3389/fimmu.2020.01755. eCollection 2020.
2
Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae.耐碳青霉烯类肺炎克雷伯菌毒力和持久性的适应性进化。
Nat Med. 2020 May;26(5):705-711. doi: 10.1038/s41591-020-0825-4. Epub 2020 Apr 13.
本文引用的文献
1
Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria.肺炎克雷伯菌作为耐药基因从环境向临床重要细菌传播的关键媒介。
Curr Opin Microbiol. 2018 Oct;45:131-139. doi: 10.1016/j.mib.2018.04.004. Epub 2018 May 1.
2
Novel, Broadly Reactive Anticapsular Antibodies against Carbapenem-Resistant Klebsiella pneumoniae Protect from Infection.新型广谱抗碳青霉烯类耐药肺炎克雷伯菌荚膜抗体可预防感染。
mBio. 2018 Apr 3;9(2):e00091-18. doi: 10.1128/mBio.00091-18.
3
Antibody-Mediated Killing of Carbapenem-Resistant ST258 by Human Neutrophils.抗体介导的人中性粒细胞对碳青霉烯类耐药 ST258 的杀伤作用。
mBio. 2018 Mar 13;9(2):e00297-18. doi: 10.1128/mBio.00297-18.
4
Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae.免疫逃避驱动的 O2 血清型流行情况以及针对多药耐药肺炎克雷伯菌的治疗性抗体的潜力。
Nat Commun. 2017 Dec 8;8(1):1991. doi: 10.1038/s41467-017-02223-7.
5
A Semi-Synthetic Glycoconjugate Vaccine Candidate for Carbapenem-Resistant Klebsiella pneumoniae.一种用于治疗碳青霉烯类耐药肺炎克雷伯菌的半合成糖缀合物疫苗候选物。
Angew Chem Int Ed Engl. 2017 Nov 6;56(45):13973-13978. doi: 10.1002/anie.201700964. Epub 2017 Oct 5.
6
Anti-LPS antibodies protect against Klebsiella pneumoniae by empowering neutrophil-mediated clearance without neutralizing TLR4.抗脂多糖抗体通过增强中性粒细胞介导的清除作用而不中和Toll样受体4来抵御肺炎克雷伯菌。
JCI Insight. 2017 May 4;2(9). doi: 10.1172/jci.insight.92774.
7
Importance of Clonal Complex 258 and IncF Plasmids among a Global Collection of Klebsiella pneumoniae with .克隆复合体258和IncF质粒在全球肺炎克雷伯菌菌株集合中的重要性 （原文结尾不完整，翻译根据现有内容尽量完整呈现）
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02610-16. Print 2017 Apr.
8
Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.美国碳青霉烯类耐药肠杆菌科细菌（CRE）感染中心地区耐碳青霉烯类肠杆菌科细菌（CRE）所致菌血症的多中心临床与分子流行病学分析
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02349-16. Print 2017 Apr.
9
Multi-institute analysis of carbapenem resistance reveals remarkable diversity, unexplained mechanisms, and limited clonal outbreaks.碳青霉烯类耐药性的多机构分析揭示了显著的多样性、不明机制及有限的克隆性暴发。
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1135-1140. doi: 10.1073/pnas.1616248114. Epub 2017 Jan 17.
10
Alternatives to antibiotics-a pipeline portfolio review.抗生素替代品-管线组合评审。
Lancet Infect Dis. 2016 Feb;16(2):239-51. doi: 10.1016/S1473-3099(15)00466-1. Epub 2016 Jan 13.
Zotero 插件